Nakajima R - Search Results

1

First-in-Human Phase 1 Study of MORAb-202, an Antibody-Drug Conjugate Comprising Farletuzumab Linked to Eribulin Mesylate, in Patients with Folate Receptor-α-Positive Advanced Solid Tumors.

Shimizu T, Fujiwara Y, Yonemori K, Koyama T, Sato J, Tamura K, Shimomura A, Ikezawa H, Nomoto M, Furuuchi K, Nakajima R, Miura T, Yamamoto N. Shimizu T, et al. Among authors: nakajima r. Clin Cancer Res. 2021 Jul 15;27(14):3905-3915. doi: 10.1158/1078-0432.CCR-20-4740. Epub 2021 Apr 29. Clin Cancer Res. 2021. PMID: 33926914 Clinical Trial.

2

A phase I study of ontuxizumab, a humanized monoclonal antibody targeting endosialin, in Japanese patients with solid tumors.

Doi T, Aramaki T, Yasui H, Muro K, Ikeda M, Okusaka T, Inaba Y, Nakai K, Ikezawa H, Nakajima R. Doi T, et al. Among authors: nakajima r. Invest New Drugs. 2019 Oct;37(5):1061-1074. doi: 10.1007/s10637-018-0713-7. Epub 2019 Jan 9. Invest New Drugs. 2019. PMID: 30623276 Free PMC article. Clinical Trial.

3

Phase 2 study of lenvatinib monotherapy as second-line treatment in unresectable biliary tract cancer: primary analysis results.

Ueno M, Ikeda M, Sasaki T, Nagashima F, Mizuno N, Shimizu S, Ikezawa H, Hayata N, Nakajima R, Morizane C. Ueno M, et al. Among authors: nakajima r. BMC Cancer. 2020 Nov 16;20(1):1105. doi: 10.1186/s12885-020-07365-4. BMC Cancer. 2020. PMID: 33198671 Free PMC article. Clinical Trial.

4

[S-1-based chemotherapy for unresectable advanced gastric cancer of the elderly or patients with renal dysfunction].

Fujiya K, Akiyama J, Yokota E, Asayama N, Ogami T, Nakajima R, Nishimura S, Sakurai T, Nagata N, Yokoi C, Kojima Y, Kobayakawa M, Gotoda T, Shimbo T, Uemura N. Fujiya K, et al. Among authors: nakajima r. Gan To Kagaku Ryoho. 2011 Nov;38(11):1817-20. Gan To Kagaku Ryoho. 2011. PMID: 22083189 Japanese.

5

Impact of Adalimumab on Work Productivity and Activity Impairment in Japanese Patients with Rheumatoid Arthritis: Large-Scale, Prospective, Single-Cohort ANOUVEAU Study.

Takeuchi T, Nakajima R, Komatsu S, Yamazaki K, Nakamura T, Agata N, Igarashi A, Tango T, Tanaka Y. Takeuchi T, et al. Among authors: nakajima r. Adv Ther. 2017 Mar;34(3):686-702. doi: 10.1007/s12325-017-0477-z. Epub 2017 Jan 31. Adv Ther. 2017. PMID: 28144917 Free PMC article.

6

[The usefulness and limitations of the new Japanese criteria for severity assessment in acute pancreatitis].

Shirai K, Sako A, Asayama N, Ogami T, Nakajima R, Nishimura S, Fujiya K, Yada T, Yamada A, Akazawa N, Sakurai T, Oshima T, Nagata N, Yago Y, Sasajima K, Kobayakawa M, Akiyama J, Yanase M, Masaki N, Uemura N. Shirai K, et al. Among authors: nakajima r. Nihon Shokakibyo Gakkai Zasshi. 2010 Jan;107(1):48-60. Nihon Shokakibyo Gakkai Zasshi. 2010. PMID: 20057183 Japanese.

7

Predicting the outcome of chronic kidney disease by the estimated nephron number: the rationale and design of PRONEP, a prospective, multicenter, observational cohort study.

Imasawa T, Nakazato T, Ikehira H, Fujikawa H, Nakajima R, Ito T, Ando Y, Yoshimura M, Nakayama M, Yahata K, Sasaki O, Yaomura T, Katafuchi R, Yamamura T, Kawaguchi T, Nishimura M, Kitamura H, Kenmochi T, Shimatsu A. Imasawa T, et al. Among authors: nakajima r. BMC Nephrol. 2012 Mar 10;13:11. doi: 10.1186/1471-2369-13-11. BMC Nephrol. 2012. PMID: 22405377 Free PMC article. Clinical Trial.

8

Economic impact of adalimumab treatment in Japanese patients with rheumatoid arthritis from the adalimumab non-interventional trial for up-verified effects and utility (ANOUVEAU) study.

Tanaka Y, Yamazaki K, Nakajima R, Komatsu S, Igarashi A, Tango T, Takeuchi T. Tanaka Y, et al. Among authors: nakajima r. Mod Rheumatol. 2018 Jan;28(1):39-47. doi: 10.1080/14397595.2017.1341459. Epub 2017 Jul 13. Mod Rheumatol. 2018. PMID: 28704126 Clinical Trial.

9

Effectiveness and safety of initiating adalimumab plus ≥12 mg/week methotrexate with adjustable dosing in biologic-naïve patients with early rheumatoid arthritis: HAWK study postmarketing surveillance in Japan.

Tanaka Y, Mimori T, Yamanaka H, Nakajima R, Morita K, Kimura J, Takeuchi T. Tanaka Y, et al. Among authors: nakajima r. Mod Rheumatol. 2019 Jul;29(4):572-580. doi: 10.1080/14397595.2018.1500979. Epub 2018 Sep 11. Mod Rheumatol. 2019. PMID: 30009649

10

Ca2+-activated reactive oxygen species production by Arabidopsis RbohH and RbohJ is essential for proper pollen tube tip growth.

Kaya H, Nakajima R, Iwano M, Kanaoka MM, Kimura S, Takeda S, Kawarazaki T, Senzaki E, Hamamura Y, Higashiyama T, Takayama S, Abe M, Kuchitsu K. Kaya H, et al. Among authors: nakajima r. Plant Cell. 2014 Mar;26(3):1069-80. doi: 10.1105/tpc.113.120642. Epub 2014 Mar 7. Plant Cell. 2014. PMID: 24610725 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

571 results

Search Page